Norris Perne French Llpmi Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Norris Perne French Llpmi reduced its stake in Stryker Corporation by 4.3% during the most recent quarter end. The investment management company now holds a total of 113,526 shares of Stryker Corporation which is valued at $13,036,191 after selling 5,097 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Jul 25, 2016.Stryker Corporation makes up approximately 2.73% of Norris Perne French Llpmi’s portfolio.

Other Hedge Funds, Including , Edmp reduced its stake in SYK by selling 1,514 shares or 5.45% in the most recent quarter. The Hedge Fund company now holds 26,265 shares of SYK which is valued at $3,016,010. Stryker Corporation makes up approx 2.83% of Edmp’s portfolio.Nikko Asset Management Americas reduced its stake in SYK by selling 900 shares or 34.62% in the most recent quarter. The Hedge Fund company now holds 1,700 shares of SYK which is valued at $208,012. Stryker Corporation makes up approx 0.02% of Nikko Asset Management Americas’s portfolio.Exxonmobil Investment Management Inc Tx boosted its stake in SYK in the latest quarter, The investment management firm added 5,034 additional shares and now holds a total of 81,316 shares of Stryker Corporation which is valued at $9,944,134. Stryker Corporation makes up approx 0.21% of Exxonmobil Investment Management Inc Tx’s portfolio.Alpha Windward reduced its stake in SYK by selling 273 shares or 11.37% in the most recent quarter. The Hedge Fund company now holds 2,128 shares of SYK which is valued at $260,233. Stryker Corporation makes up approx 0.19% of Alpha Windward’s portfolio.

Stryker Corporation opened for trading at $114.97 and hit $116.62 on the upside on Friday, eventually ending the session at $116.28, with a gain of 1.15% or 1.32 points. The heightened volatility saw the trading volume jump to 14,53,717 shares. Company has a market cap of $43,524 M.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.